CVS Health Corporation(CVS)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Latest News & Analysis
CVS Health Corporation: Strategic GLP-1 Market Positioning Amid Regulatory Challenges and Digital Innovation
CVS Health navigates GLP-1 market dominance with Wegovy prioritization, faces DOJ Medicare Advantage scrutiny, and invests in AI-driven healthcare transformation.
CVS Health Corporation Latest Market Update: Strategic Formulary Shift and Financial Overview
CVS Health pivots its formulary strategy by excluding Zepbound in favor of Wegovy, impacting market dynamics and financials amid evolving PBM cost management.
CVS Health Corporation: Latest Financial Insights and Strategic Developments for Investors
Explore CVS Health's recent financial performance, strategic shifts, and market positioning with detailed data analysis and actionable investor insights.
CVS Health Corporation Latest Strategic Win and Q2 Earnings Analysis | Monexa AI
Explore CVS Health's $250M CalPERS PBM contract win, Q2 2025 earnings outlook, and strategic resilience amid Medicare Advantage challenges and regulatory scrutiny.
CVS Health Corporation Legal Challenges and Strategic Financial Outlook Analysis
CVS Health faces a $948.8M Omnicare penalty and DOJ probes impacting Q2 earnings, while Medicare Advantage and PBM contracts shape its financial resilience.
CVS Health Corporation Q2 2025 Update: Medicare Advantage Growth Amid DOJ Investigation
CVS Health reports strong Medicare Advantage growth and revised 2024 guidance, balancing operational gains with DOJ Omnicare litigation risks.
CVS Health Corporation DOJ Medicare Advantage Investigation and Financial Impact Analysis
Explore CVS Health's DOJ Medicare Advantage investigation, Omnicare penalty, and financial analysis including revenue trends, margins, and dividend sustainability.
CVS Health Faces $948.8M Omnicare Penalty: Financial and Strategic Impact Analysis
CVS Health's Omnicare unit incurs a $948.8M penalty for fraudulent billing, impacting CVS's financials and compliance posture amid ongoing regulatory scrutiny.
CVS Health Corporation Q1 2025 Earnings and DOJ Medicare Advantage Probe Analysis
CVS Health posts strong Q1 2025 results and raises guidance amid DOJ Medicare Advantage investigation, balancing operational growth with regulatory risks.
CVS Health Corporation: Navigating DOJ Medicare Investigation Amid Solid Financials
CVS Health faces DOJ Medicare Advantage kickback allegations amid strong earnings, strategic shifts, and competitive pressures in healthcare.
CVS Health Corporation Latest Developments: Strategic Growth Amid DOJ Medicare Probe
CVS Health shows strong stock surge and integrated care growth despite DOJ Medicare Advantage investigation, revealing key financial metrics and strategic outlook.
CVS Health Corporation: Navigating Medicare Advantage Investigation Amid Strategic Growth and Financial Resilience
Explore CVS Health's Medicare Advantage investigation, financial performance, and strategic initiatives highlighting regulatory challenges and growth opportunities.
CVS Health: Navigating DOJ Probe & $95M Medicare Judgment Impact
CVS Health faces escalating legal scrutiny, including a DOJ probe into Medicare Advantage and a $95M judgment, impacting its financial performance and strategic direction.
CVS Health Stock Analysis: Legal Challenges & Growth Opportunities
CVS Health faces legal scrutiny and strategic pivots. Explore its financial resilience, GLP-1 growth, and operational efficiencies amidst ongoing challenges.
CVS Health: Strategic Pivot Drives Stock Surge Amidst Profitability Shifts
CVS Health's stock surged +54% YTD despite a net income decline, signaling market confidence in its healthcare services expansion and strategic regulatory positioning.
CVS Health: Digital Transformation & Q1 MBR Improvement
CVS Health is investing $20B in digital health, showing improved Q1 2025 MBR. This analysis covers its strategy, financials, and market positioning.
CVS Health Analysis: Earnings Beat, $20B Digital Investment, and Strategic Outlook
CVS Health navigates digital transformation, retail shifts, and regulatory scrutiny while reporting strong Q1 2025 results and raising full-year guidance.
CVS Health: Navigating a $20B Digital Future Amidst Financial Pressures
CVS Health is embarking on a $20B digital transformation amid significant profit decline and legal challenges, reshaping its future trajectory.
CVS Health: CFO Transition, Medicare Boost, and Strategic Outlook
CVS Health navigates a dynamic healthcare landscape with a new CFO and a boost from Medicare Advantage payments, balancing debt management and growth.
CVS Health: Dividend, Tariffs, and Strategic Financial Outlook
A deep dive into CVS Health's dividend policy, market resilience, and strategic shifts amidst financial challenges. Gain insights into their cost-cutting plans and future outlook.
CVS Health: Dividend, Weight Loss Program, and Store Strategy
CVS Health navigates the healthcare landscape with its weight management program and strategic store realignment, impacting dividends, stock performance, and debt levels.
CVS Health: Weight Management, Digital Transformation, and Financials
CVS Health navigates healthcare's evolution with weight management, digital initiatives, and pharmacy-focused stores. Financials show mixed performance, but strategic alignments suggest growth potential.
CVS Health: Weight Management, Pharmacy Strategy, and Digital Transformation
CVS Health strategically adapts to the evolving healthcare landscape. Focus on weight management, smaller pharmacy stores, and digital transformation.
CVS Health: Smaller Stores, Medicare Challenges, and Future
CVS Health navigates strategic shifts with smaller stores and Medicare challenges. A deep dive into financials, market dynamics, and future prospects for investors.
CVS Health: Strategic Shifts, Financials, and Market Impact
Analysis of CVS Health's strategic shifts, financial performance, and market impact. Examines store changes, Wellvana acquisition, community health, and Medicare challenges.
CVS Health Corporation: Strategic Financial Analysis & Insights
Detailed analysis of CVS Health's recent strategic moves, financial performance, and market positioning for informed investors.
CVS Health: Adapting to the Evolving Healthcare Landscape
A deep dive into CVS Health's CostVantage, gene therapy payment models, and stock volatility. Explore challenges, opportunities, and strategic implications for investors.
CVS Health: Navigating Healthcare Costs and Market Shifts in 2025
CVS Health navigates rising healthcare costs, expands flu services, and manages Medicare Advantage challenges. Cost-cutting and strategic adjustments are key.
CVS Health: Navigating Challenges and Opportunities in 2025
CVS Health navigates market volatility, Medicare challenges, and strategic shifts in 2025. Key developments, cost measures, and analyst insights examined.
CVS Health: Navigating Medicare Pressures, Strategic Shifts, and Economic Headwinds
CVS Health navigates Medicare pressures, strategic shifts, and economic headwinds, impacting its financial performance and future prospects. Key challenges and opportunities analyzed.
CVS Health: Challenges, Opportunities, and Strategic Outlook for 2025
CVS Health faces Medicare challenges, manages gene therapy costs, and navigates interest rate impacts in 2025. A comprehensive analysis of its strategic outlook.
CVS Health: Navigating Medicare Pressures and Market Volatility
CVS Health navigates Medicare pressures, cost-cutting, and gene therapy risks amidst market volatility. Analyst views mixed as CVS adapts to a changing healthcare landscape.
CVS Health: Navigating Market Developments and Industry Trends in 2025
A comprehensive, data-driven analysis of CVS Health’s earnings, leadership changes, digital innovations, and market strategy.
CVS Health: Is the Turnaround Real? Analyzing Q4 Earnings, Stock Rally, and Strategic Shifts
A deep dive into CVS Health’s Q4 2024 performance, stock surge, and strategic initiatives driving its turnaround.
CVS Health Turnaround Strategy 2025: Navigating Challenges and Opportunities
Explore CVS Health’s Q4 2024 earnings, leadership shifts, and strategic moves to drive a turnaround in 2025.